Advertisement

Diabetologia

, Volume 34, Issue 5, pp 356–361 | Cite as

Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up

  • A. Fontbonne
  • M. A. Charles
  • N. Thibult
  • J. L. Richard
  • J. R. Claude
  • J. M. Warnet
  • G. E. Rosselin
  • E. Eschwège
Originals

Summary

The Paris Prospective Study is a long-term, largescale study of the factors predicting coronary heart disease. The first follow-up examination included, for subjects not known as having diabetes mellitus, a 75 g oral glucose tolerance test with measurement of plasma insulin and glucose levels, fasting and 2 h post-load. Between 1968 and 1973, 6903 men aged 43–54 years were thus examined. Causes of death were ascertained within this group after 15 years of mean follow-up. The baseline variables were tested as predictors of death from coronary heart disease by a Cox regression analysis. Significant independent predictors of coronary heart disease death were: systolic blood pressure, number of cigarettes per day, plasma cholesterol level, and 2 h post-load plasma insulin level when entered as a categorical variable (below or above 452 pmol/l, i.e. the lower limit of the fifth quintile of the distribution). This dichotomization was performed to account for the non-linear univariate distribution of deaths with increasing post-load insulin values. Fasting plasma insulin level was not an independent predictor of death by coronary heart disease over this long-term follow-up. Levels of blood glucose were not significant independent predictors of death by coronary heart disease when plasma insulin levels were included in the model. The same applied to abnormalities of glucose tolerance when the 125 men with known non-insulin-treated diabetes at baseline were added to the group. Under the assumption that hyperinsulinaemia is a marker of insulin resistance, the results are consistent with the hypothesis that insulin resistance is associated with a higher risk of coronary heart disease mortality. However, it is doubtful that circulating insulin per se is a direct cause of arterial complications.

Key words

Epidemiology Paris Prospective Study coronary heart disease risk factors plasma insulin level insulin resistance 

References

  1. 1.
    Eschwège E, Richard JL, Thibult N, Ducimetière P, Warnet JM, Claude JR, Rosselin GE (1985) Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res 15 [Suppl]: 41–46Google Scholar
  2. 2.
    Pyörälä K, Savolainen E, Kaukola S, Haapakoski J (1985) Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand 701 [Suppl]: 38–52Google Scholar
  3. 3.
    Welborn TA, Wearne K (1979) Coronary heart disease and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2: 154–160Google Scholar
  4. 4.
    Stout RW (1990) Insulin and atheroma. 20-yr perspective. Diabetes Care 13: 631–654Google Scholar
  5. 5.
    Jarrett RJ (1988) Is insulin atherogenic? Diabetologia 31: 71–75Google Scholar
  6. 6.
    Hill AB (1965) The environment and disease: association or causation? Proc Roy Soc Med 58: 295–300Google Scholar
  7. 7.
    Ducimetière P, Richard JL, Claude JR (1981) Les cardiopathies ischémiques: incidence et facteurs de risque. L'Etude Prospective Parisienne. Editions INSERM, ParisGoogle Scholar
  8. 8.
    Rosselin G, Assan R, Yalow RS, Berson SA (1966) Separation of antibody bound and unbound peptide hormone labelled with iodine 131 by talcum powder and precipitates silica. Nature 212: 355–357Google Scholar
  9. 9.
    Richard JL (1973) Quelques informations sur la fréquence en France des maladies cardiovasculaires, particulièrement des cardiopathies ischémiques. In: Ducimetière P (ed) Epidémiologie et prévention des maladies cardiovasculaires. Colloques de l'INSERM, Vol 21. Editions INSERM, Paris, pp 11–46Google Scholar
  10. 10.
    Cox DR (1972) Regression models and life tables (with discussion). J Roy Statist Soc B 34: 187–220Google Scholar
  11. 11.
    SAS Institute Inc (1985) AS User's Guide: Statistics. Version 5 Edition. SAS Institute Inc, Cary NCGoogle Scholar
  12. 12.
    WHO Expert Committee (1985) Diabetes Mellitus. Technical Report Series 727, WHO, GenevaGoogle Scholar
  13. 13.
    Fontbonne A, Eschwège E, Cambien F, Richard JL, Ducimetière P, Thibult N, Warnet JM, Claude JR, Rosselin GE (1989) Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32: 300–304Google Scholar
  14. 14.
    Stalder M, Pometta D, Suenram A (1981) Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men. Diabetologia 21: 544–548Google Scholar
  15. 15.
    Laakso M, Pyörälä K, Voutilainen E, Marniemi J (1987) Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects. Am J Epidemiol 125: 611–621Google Scholar
  16. 16.
    Temple RC Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN (1989) Insulin deficiency in non-insulin-dependent diabetes. Lancet 1: 293–295Google Scholar
  17. 17.
    Nagi DK, Hendra TJ, Ryle AJ, Cooper TM, Temple RC, Clark PMS, Schneider AE, Hales CN, Yudkin JS (1990) Relationships of concentrations of insulin, intact pro-insulin and 32–33 split pro-insulin with cardiovascular risk factors in Type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 33: 532–537Google Scholar
  18. 18.
    Nikkilä EA, Miettinen TA, Vesenne MR, Pelkonen R (1965) Plasma insulin in coronary heart disease. Lancet II: 508–511Google Scholar
  19. 19.
    Stout RW, Vallance-Owen J (1979) Insulin and atheroma. Lancet I: 1078–1080Google Scholar
  20. 20.
    Pyörälä K (1979) Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2: 131–141Google Scholar
  21. 21.
    Ducimetière P, Eschwège E, Papoz L, Richard JL, Claude JR, Rosselin GE (1980) Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19: 205–210Google Scholar
  22. 22.
    Tobey TA, Greenfield M, Kraemer F, Reaven GM (1981) Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism 30: 165–171Google Scholar
  23. 23.
    Ferrannini E, Buzzigoli G, Bonnadonna R, Gioricco MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S (1987) Insulin resistance in essential hypertension. N Engl J Med 317: 350–357Google Scholar
  24. 24.
    Fossati P, Romon-Rousseaux M (1987) Insulin and HDL-cholesterol metabolism. Diab Métab (Paris) 13: 390–394Google Scholar
  25. 25.
    Bogardus C, Lillioja S, Howard B, Reaven GM, Mott D (1984) Relationships between insulin secretion, insulin action and fasting plasma glucose concentration in non-diabetic and non-insulin-dependent diabetic subjects. J Clin Invest 74: 1238–1246Google Scholar
  26. 26.
    Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z (1985) Hyperinsulinemia, a link between hypertension, obesity, and glucose intolerance. J Clin Invest 75: 809–817Google Scholar
  27. 27.
    Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergorzani M, Gnudi L, Passeri M, Reaven GM (1989) Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320: 702–706Google Scholar
  28. 28.
    Pyörälä K, Uusitupa M, Laakso M, Siitonen O, Niskanen L, Rönnemaa T (1987) Macrovascular complications in relation to hyperinsulinemia in non-insulin-dependent diabetes mellitus. Diab Métab (Paris) 13: 345–349Google Scholar
  29. 29.
    Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595–1607Google Scholar
  30. 30.
    Foster DW (1989) Insulin resistance, a secret killer? N Engl J Med 320: 733–734Google Scholar
  31. 31.
    Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256: 2835–2838Google Scholar
  32. 32.
    Betteridge DJ (1989) High density lipoprotein cholesterol and coronary heart disease. Br Med J 298: 975–976Google Scholar
  33. 33.
    Castelli WP (1986) The triglyceride issue: a view from Framingham. Am Heart J 112: 432–437Google Scholar
  34. 34.
    Austin MA (1989) Plasma triglyceride as a risk factor for coronary heart disease: the epidemiologic evidence and beyond. Am J Epidemiol 129: 249–259Google Scholar
  35. 35.
    Sicree RA, Zimmet PZ, King HOM, Coventry JS (1987) Plasma insulin response among Nauruans: prediction of deterioration in glucose tolerance over 6 years. Diabetes 36: 179–186Google Scholar
  36. 36.
    Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennnett PH (1988) The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 319: 1500–1506Google Scholar
  37. 37.
    Charles MA, Fontbonne A, Eschwège E (1988) Risk factors of Type 2 (non-insulin-dependent) diabetes in a Caucasian population. Diabetologia 31: 479 (Abstract)Google Scholar
  38. 38.
    Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK (1990) Incidence of Type 2 diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body fat distribution. Diabetes 39: 283–288Google Scholar
  39. 39.
    Leslie RDG, Volkmann HP, Poncher M, Hanning I, Orskov H, Alberti KGMM (1986) Metabolic abnormalities in children of non-insulin-dependent diabetics. Br Med J 293: 840–842Google Scholar
  40. 40.
    Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK (1988) Increased insulin concentrations in non-diabetic offspring of diabetic parents. N Engl J Med 319: 1297–1301Google Scholar
  41. 41.
    Ho LT, Chang ZY, Wang JT, Li SH, Liu YF, Chen YDI, Reaven GM (1990) Insulin insensitivity in offspring of parents with Type 2 diabetes mellitus. Diab Med 7: 31–34Google Scholar
  42. 42.
    Jarrett RJ, Shipley MJ (1988) Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease — putative association via common antecedents: further evidence from the Whitehall Study. Diabetologia 31: 737–740Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • A. Fontbonne
    • 1
  • M. A. Charles
    • 1
  • N. Thibult
    • 1
  • J. L. Richard
    • 2
  • J. R. Claude
    • 3
  • J. M. Warnet
    • 3
  • G. E. Rosselin
    • 4
  • E. Eschwège
    • 1
  1. 1.INSERM U21VillejuifFrance
  2. 2.INSERM U258ParisFrance
  3. 3.Center for Prevention of Cardiovascular DiseasesDASESParisFrance
  4. 4.INSERM U55ParisFrance

Personalised recommendations